» Articles » PMID: 29264763

Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells

Overview
Journal J Mol Neurosci
Date 2017 Dec 22
PMID 29264763
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence shows that Disheveled-Axin domain containing 1 (DIXDC1) is dysregulated in various cancers. However, the role of DIXDC1 in retinoblastoma (RB) remains unclear. In this study, we aimed to investigate the biological function of DIDXDC1 in RB and the way in which its expression is regulated by microRNAs (miRNAs). We found that DIXDC1 expression was significantly upregulated in RB cell lines. The silencing of DIXDC1 by small interfering RNA (siRNA) significantly inhibited the proliferation, invasion, and Wnt signaling in RB cell lines. Interestingly, DIXDC1 was identified as a target gene of miR-186. The expression of DIXDC1 was negatively regulated by miR-186, and DIXDC1 expression was inversely correlated with miR-186 expression in RB clinical specimens. Overexpression of miR-186 inhibited the proliferation, invasion, and Wnt signaling in RB cell lines. Moreover, overexpression of DIXDC1 markedly reversed the antitumor effect of miR-186. Overall, our results reveal that DIXDC1 functions as a potential oncogene in RB, and inhibiting DIXDC1 by miR-186 suppresses the proliferation and invasion of RB cell lines. Our study suggests that DIXDC1 and miR-186 may serve as novel therapeutic targets for the treatment of RB.

Citing Articles

MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes.

Zamani Sani M, Mirzaei M, Mota A, Mohammadian J, Beilankouhi E, Rahmati M Biochem Genet. 2025; .

PMID: 39862293 DOI: 10.1007/s10528-024-10976-2.


The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer.

Azzam H, El-Derany M, Wahdan S, Faheim R, Helal G, El-Demerdash E Hum Cell. 2023; 36(6):1877-1886.

PMID: 37646973 PMC: 10587280. DOI: 10.1007/s13577-023-00977-5.


Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.


Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer.

Azzam H, El-Derany M, Wahdan S, Faheim R, Helal G, El-Demerdash E Sci Rep. 2022; 12(1):16118.

PMID: 36167713 PMC: 9515205. DOI: 10.1038/s41598-022-19977-w.


The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA.

Xiang Y, Tian Q, Guan L, Niu S Front Oncol. 2020; 10:233.

PMID: 32195180 PMC: 7066114. DOI: 10.3389/fonc.2020.00233.


References
1.
Wang L, Cao X, Chen Q, Zhu T, Zhu H, Zheng L . DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation. Cancer Sci. 2009; 100(10):1801-8. PMC: 11159846. DOI: 10.1111/j.1349-7006.2009.01246.x. View

2.
Yan X, Lyu T, Jia N, Yu Y, Hua K, Feng W . Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway. PLoS One. 2013; 8(5):e63731. PMC: 3648479. DOI: 10.1371/journal.pone.0063731. View

3.
Wang J, Liu X, Yang Z, Xie B, Zhong Y . The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells. BMC Cancer. 2014; 14:89. PMC: 3931292. DOI: 10.1186/1471-2407-14-89. View

4.
Wang L, Tan C, Qiao F, Wang W, Jiang X, Lian P . Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis. Cancer Cell Int. 2015; 15:120. PMC: 4683926. DOI: 10.1186/s12935-015-0273-2. View

5.
Zhang Y, Zhu X, Zhu X, Wu Y, Liu Y, Yao B . MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5. Tumour Biol. 2017; 39(3):1010428317691674. DOI: 10.1177/1010428317691674. View